By Josh White
Date: Thursday 10 Apr 2025
(Sharecast News) - Tristel announced on Thursday that it has submitted the additional information requested by the US Food and Drug Administration for its Tristel OPH disinfectant, moving the product closer to potential FDA clearance, which it now expects by the end of June.
Additional info. submitted to FDA for Tristel OPH | 10-Apr-2025 | 07:00 | RNS |
Publication of Poster by Mayo Clinic & US update | 09-Apr-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 02-Apr-2025 | 07:00 | RNS |
Holding(s) in Company | 31-Mar-2025 | 08:56 | RNS |
Director/PDMR Shareholding | 26-Mar-2025 | 10:30 | RNS |
Cash planted into TEG | 11-Nov-2007 | Scotland on Sunday |
Space at a premium | 05-Nov-2006 | Scotland on Sunday |
Strong showing from metals and oil lifts Footsie | 30-Oct-2007 | Guardian |
Small caps | 30-Oct-2007 | Times |
Commodity shares lead the way | 09-Jul-2007 | Guardian |
Mortgage banks and housebuilders knock Footsie | 28-Jun-2007 | Guardian |
Commodities outlook buoys Anglo American | 20-Feb-2007 | Guardian |
No recent information was found.
Currency | UK Pounds |
Share Price | 348.33p |
Change Today | -6.67p |
% Change | -1.88 % |
52 Week High | 500.00p |
52 Week Low | 270.00p |
Volume | 8,918 |
Shares Issued | 47.70m |
Market Cap | £166.16m |
RiskGrade | 180 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 20-Mar-25 | 28-Nov-24 |
Paid | 11-Apr-25 | 20-Dec-24 |
Amount | 5.68p | 8.28p |
Time | Volume / Share Price |
11:35 | 256 @ 349.65p |
11:22 | 716 @ 349.65p |
10:53 | 2,558 @ 351.80p |
10:32 | 72 @ 345.50p |
09:44 | 479 @ 349.22p |
Finance Director | Elizabeth Dixon |
CEO | Matthew (Matt) Giovanni Sassone |
You are here: research